Latest filing published 25 May 2016 for OMNICELL, INC..
Insider track record
No signal scores available.
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -9.7%Entry US$13.34 · Close at T+365 US$12.05
- -21.5%Entry US$14.05 · Close at T+365 US$11.03
- -15.0%Entry US$12.70 · Close at T+365 US$10.80
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Randy D. Lindholm: trading record in brief
Randy D. Lindholm is a declared insider of Omnicell, Inc., with filings sourced from SEC (Form 4). We count 77 filings; the first trade dates from 25 October 2006 and the latest from 24 May 2016.
Both buying and selling appear: 3 purchases worth €147k, against 38 sales worth €2.2M. The net balance comes to €2.1M on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 20 share grants and 16 option exercises.
The median purchase comes to €36k. For 3 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 33% of cases, with a median move of -9.3%. This is a record of the past, not a forecast.
The newest entry dates from 25 May 2016: a share grant, in Omnicell, Inc. The latest purchase dates back some time: it was published 6,621 days ago, on 22 September 2008. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Randy D. Lindholm
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,798 shares0Common StockSEC:0001179110-16-025511:0
- 633 shares0Common StockSEC:0001179110-16-025511:1
- 3,328 shares0Common StockSEC:0001179110-15-008353:0
- 554 shares0Common StockSEC:0001179110-15-008353:1
- 5,000 shares@ US$22.63Common StockSEC:0001179110-14-016523:0
- 5,000 shares@ US$31.72Common StockSEC:0001179110-14-016523:1
- 4,533 shares0Common StockSEC:0001179110-14-010636:0
- 755 shares0Common StockSEC:0001179110-14-010636:1
- 4,442 shares@ US$26.95Common StockSEC:0001179110-14-002645:0
- 1,065 shares@ US$23.00Common StockSEC:0001179110-13-016460:0
- 2,522 shares@ US$23.00Common StockSEC:0001179110-13-016460:1
- 838 shares@ US$22.90Comment StockSEC:0001179110-13-016460:2
- 6,263 shares@ US$22.95Commen StockSEC:0001179110-13-016460:3
- 17,443 shares@ US$9.25Common StockSEC:0001179110-13-010234:0
- 17,443 shares@ US$19.14Common StockSEC:0001179110-13-010234:1
- 6,458 shares@ US$19.14Common StockSEC:0001179110-13-010234:2
- 6,511 shares0Common StockSEC:0001179110-13-009026:0
- 759 shares0Common StockSEC:0001179110-13-009026:1
- 1,414 shares@ US$17.46Common StockSEC:0001179110-13-002800:11
- 4,324 shares@ US$17.46Common StockSEC:0001179110-13-002800:12
- 2,162 shares@ US$17.46Common StockSEC:0001179110-13-002800:13
- 5,000 shares@ US$12.10Common StockSEC:0001179110-13-002107:0
- 5,000 shares@ US$17.46Common StockSEC:0001179110-13-002107:1
- 2,720 shares@ US$11.91Common StockSEC:0001179110-13-002107:2
- 2,720 shares@ US$17.46Common StockSEC:0001179110-13-002107:3
25 of 65 declarations